Showing results (1-10 of 100) with videos related to
Sort By:
Pageof 10
F1000 Medicine Reports|October 16, 2010
New oral disease-modifying therapies for multiple sclerosisBridget A Bagert, Dennis BourdetteCurrent Neurology and Neuroscience Reports|August 12, 2009
Epstein-Barr virus in multiple sclerosisBridget A BagertArchives of Neurology|July 13, 2011
Chronic cerebrospinal venous insufficiency and multiple sclerosisBridget A Bagert, Ellen Marder, Olaf StüveOchsner Journal|April 16, 2019
Gadolinium Deposition in Neurology Clinical PracticeTyler E Smith, Andrew Steven, Bridget A BagertOchsner Journal|April 16, 2019
Anti-N-Methyl-D-Aspartate Receptor Encephalitis in a Patient With Antithyroid Peroxidase Antibodies and a Parotid Pleomorphic AdenomaKarlyndsay Sitterley, Tara von Kleist, Bridget A BagertNeurology. Clinical Practice|November 7, 2013
Postmarketing adverse drug reactions: A duty to report?Eran Klein, Dennis BourdetteCurrent Neurology and Neuroscience Reports|July 5, 2012
New disease-modifying therapies and new challenges for MSVijayshree Yadav, Dennis BourdetteCurrent Neurology and Neuroscience Reports|April 26, 2006
Complementary and alternative medicine: is there a role in multiple sclerosis?Vijayshree Yadav, Dennis BourdetteCurrent Neurology and Neuroscience Reports|July 13, 2011
The radiologically isolated syndrome: look (again) before you treatRebecca Spain, Dennis BourdetteNeurology|October 8, 2013
Tumefactive multiple sclerosis and fingolimod: Immunotherapies and unintended consequencesFriedemann Paul, Dennis BourdettePageof 10